Twenty-Five Year Political Veteran Sam Myers, Jr. Named President of Direct Impact
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Sam Myers, Jr., has been named President of Direct Impact (DI), the nation's leading grassroots campaign firm and member of BCW Group. Myers is based in Washington, D.C., and is charged with building DI’s industry-leading work in developing local market campaigns that drive communities to take action around various public affairs, public education and corporate reputation issues.
“I am thrilled that Sam will be leading DI,” said Chris Foster, President of BCW North America. “His more than two decades of political campaign experience and having served at the highest levels of government will be invaluable to clients that are navigating increasingly complex communications and legislative environments.”
Myers has served in two presidential administrations and worked on six presidential campaigns. From 2009 to 2017 he served in the Obama administration, in multiple leadership roles. For the U.S. Department of Education, his efforts in the Office of the Secretary and as head of Office of the White House Liaison helped put in place policies that supported narrowing the skills gap, job creation, healthy eating in schools and America’s College Promise.
Myers also spearheaded change management and communication for Department of Commerce’s move to a department-wide, enterprise services model. For the White House, he led delegations to the Vatican, UN General Assembly and Aspen Ideas Festival. In the Clinton administration, he served as an advance staffer for President Clinton and as a Defense Fellow at the U.S. Department of Defense.
Upon leaving the public sector in 2017, Myers transitioned to Brooklyn-based Huge, Inc., working in a series of roles, most recently Vice President for Partnerships and Development, where he developed thought leadership platforms around autonomous vehicles, aerospace, maternal health and the future of work; created partnerships at SXSW, CES and Cannes, among others; and drove strategic growth for Huge’s Washington, D.C. office and global business. He then served as a Senior Vice President for San Francisco-based The OutCast Agency, charged with expanding the agency’s Washington, D.C. presence.
“Across my 25 years in campaigns, politics and public affairs, the one constant I have seen is how powerful it is when companies and organizations connect with people on their own turf about the issues they care about the most,” said Myers. “I have watched and marveled at the extraordinary work DI has done in this area and I jumped at the chance to lead this great team.”
Myers’ campaign experience includes working on Hillary for America 2016; Obama for America; John Edwards for President 2008; Kerry Edwards 2004; Gore/Lieberman 2000; Clinton/Gore 1996 and founding DC based Myers Strategies in 2004, focused on effective messaging through national grass roots events.
About Direct Impact
Founded in 1988, Direct Impact (DI) is a wholly owned subsidiary of BCW and a member of the WPP family. DI is a premier grassroots communications firm, specializing in public affairs, public education and corporate reputation campaigns. DI provides a complete range of services essential to conducting successful localized campaigns, focusing on legislative battles as well as corporate branding challenges across the country. DI has led winning, community-driven campaigns for more than half of the Fortune 50, as well as major trade associations and coalitions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190924005903/en/
Contact information
Media: Catherine Sullivan
Phone: 212.601.3205
Email:
Catherine.Sullivan@bcw-global.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom